Drug
Recombinant human thrombopoietin clinical trials
- studies test it
- 45
- open now
- 7
- in phase 3
- 19
- first study started
- 1998
Keep track of what changes. Save the recombinant human thrombopoietin studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
- rhTPO
- 31
Combined with it in one product
Studies by the year they started
45 studies that test it; most in 2022 (8)
| Year | Studies |
|---|---|
| 1998 | 1 |
| 2000 | 1 |
| 2001 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 3 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 5 |
| 2015 | 2 |
| 2016 | 2 |
| 2018 | 3 |
| 2019 | 4 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 8 |
| 2023 | 2 |
| 2024 | 2 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 1
- 6
- Phase 2
- 12
- Phase 3
- 19
- Phase 4
- 8
- No phase
- 4
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 42
Shandong University (9) · Peking Union Medical College Hospital (3) · Huihan Wang (3) · Peking University People's Hospital (3) · Institute of Hematology & Blood Diseases Hospital, China (2) · Nanfang Hospital, Southern Medical University (2) · Shenyang Sunshine Pharmaceutical Co., LTD. (2) · Mei Feng (1)
Often tested with
Tested in the same studies.
Hetrombopag (2) · Decitabine (1) · Carboplatin (1) · Etoposide (1) · Ifosfamide (1) · Granulocyte Colony-Stimulating Factor (1) · Filgrastim (1) · Thrombopoietin Receptor Agonist (1)
Studies
Open first, then newest update. How each study uses recombinant human thrombopoietin is read from its arms, and is right about nine times in ten.
Testing it · 45
- rhTPO + CsA vs CsA in the Treatment of LR-MDS With ThrombocytopeniaNot yet recruitingPhase 3Peking Union Medical College HospitalNCT07653581Written as rhTPO
- A Study of Hetrombopag Combined With rhTPO in the Treatment of Cancer Therapy-induced Thrombocytopenia (CTIT) in Solid Tumor Patients.Not yet recruitingPhase 2Sun Yat-sen UniversityNCT07334093Written as rhTPO + hetrombopag
- Efficacy and Safety of rhTPO in Combination With Cyclosporine Versus Cyclosporine Alone in the Treatment of TD-NSAANot yet recruitingPhase 4Peking Union Medical College HospitalNCT06525948Written as rhTPO
- The Effect of REcombinant Human Thrombopoietin (rhTPO) on Sepsis Patients With aCUte Severe thrombocytopEniaRecruitingPhase 2/3Ruilan WangNCT02707497Written as rhTPO
- Efficacy and Safety of rhTPO's Prophylactic Treatment of CTIT in Patients With High Risk of Cardiac InjuryRecruitingPhase 4The First Affiliated Hospital of Dalian Medical UniversityNCT05411705Written as rhTPO
- Dual Growth Factor (rhTPO + G-CSF) and Chemotherapy Combination Regimen in Acute Myeloid Leukemia: Study Protocol for a Randomized Controlled TrialRecruitingPhase 3Huihan WangNCT05382390Written as rhTPO
- Dual Growth Factor (rhTPO + G-CSF) and Chemotherapy Combination Regimen for Elderly Patients With Acute Myeloid Leukemia: A Phase II Single-Arm Multicenter StudyRecruitingNot applicableHuihan WangNCT05258799Written as rhTPO
- A Prospective Study of the Early Treatment of Recombinant Human Thrombopoietin for Chemoradiation Induced Thrombocytopenia in Cervical Squamous Cell Carcinoma PatientCompletedNot applicableMei FengNCT07649395Written as rhTPO
- Efficacy and Safety of rhTPO for the Treatment of Thrombocytopenia After Chemotherapy in AML PatientsCompletedPhase 4Institute of Hematology & Blood Diseases Hospital, ChinaNCT02267993Written as recombinant human thrombopoietin
- A Randomized Trial Comparing Optimized rhTPO Treatment With Eltrombopag Treatment in Pre-treated ITP PtsCompletedPhase 4Institute of Hematology & Blood Diseases Hospital, ChinaNCT05583838Written as rhTPO
- Phase I Study to Evaluate rhTPO in Healthy Caucasian VolunteersCompletedPhase 13SBIO AU PTY LTDNCT06630494Written as Recombinant human thrombopoietin for injection (rhTPO)
- The Effect of Prophylactic TPO Combined with BMS-IMRT to Esophageal Cancer PatientsCompletedPhase 2JIANYANG WANGNCT05944809Written as rhTPO
- IVIg Plus Low Dose rhTPO for ITP in PregnancyStatus unknownPhase 2Peking University People's HospitalNCT05634824Written as intravenous immunoglobulin plus low dose recombinant human thrombopoietin (rhTPO)
- A Clinical Study of Herombopag in Tumors-associated ThrombocytopeniaStatus unknownPhase 2The First Affiliated Hospital of Zhengzhou UniversityNCT05350956Written as TPO-RA (Herombopag) and rhTPO(Recombinant human thrombopoietin)
- Herombopag + rhTPO in Severe Immune ThrombocytopeniaStatus unknownPhase 3Yin JieNCT05328804Written as rhTPO
- Effects of Recombinant Human Thrombopoietin on Platelet Levels in ICU PatientsStatus unknownPhase 4Nanfang Hospital, Southern Medical UniversityNCT05217719Written as recombinant human thrombopoietin
- A Phase Ib Clinical Study for rhTPO in the Treatment of Thrombocytopenia in Patients With Chronic Liver DiseaseStatus unknownPhase 1Shenyang Sunshine Pharmaceutical Co., LTD.NCT05193201Written as recombinant human thrombopoietin injection
- Eltrombopag Plus rhTPO Versus Eltrombopag for ITP During the COVID-19 Pandemic (ELABORATE-19)Status unknownPhase 2Peking University People's HospitalNCT04516837Written as rhTPO
- Fixed Low-dose Eltrombopag and rhTPO for Immune Thrombocytopenia (FLOWER)Status unknownPhase 1Peking University People's HospitalNCT04518878Written as rhTPO
- Prospective Study of Patients With Thrombocytopenia Following HSCTCompletedPhase 3The First Affiliated Hospital of Soochow UniversityNCT02487563Written as rhTPO
See all 45 studies that test recombinant human thrombopoietin →
Given in every arm · 2 — recombinant human thrombopoietin is usual care beside what is tested
- Decitabine and Umbilical Cord Blood for Poor Graft Function Post Allo-HSCTNot yet recruitingPhase 3The First Affiliated Hospital of Soochow UniversityNCT05669079Written as Recombinant human thrombopoietin / thrombopoietin receptor agonist
- The Combination of Prednisone and Recombinant Human Thrombopoietin for Treatment of Immune Thrombocytopenia in PregnancyStatus unknownPhase 2Peking University People's HospitalNCT05333744Written as Recombinant Human TPO
As the comparator · 3 — what is tested is compared with recombinant human thrombopoietin
- Romiplostim Versus rhTPO for Platelet Engraftment After Transplant in MDS and AARecruitingPhase 2The First Affiliated Hospital of Soochow UniversityNCT07400341Written as Recombinant Human Thrombopoietin
- A Multicenter Randomized Controlled Study on the Treatment of Refractory CTIT With Romiplostim N01 Compared to Recombinant Human ThrombopoietinNot yet recruitingPhase 3Shandong UniversityNCT06440824Written as Recombinant Human Thrombopoietin
- Efficacy and Safety of Avatrombopag vs. Avatrombopag Combined With rhTPO in the Treatment of SAANot yet recruitingPhase 2Institute of Hematology & Blood Diseases Hospital, ChinaNCT06254287Written as Avatrombopag +rhTPO
Codes
What other systems call recombinant human thrombopoietin · ClinicalTrials.gg INT016402
- UNII (FDA) E2E529W34DRECOMBINANT HUMAN THROMBOPOIETINOne source FDA
- NCI Thesaurus C878Recombinant Human ThrombopoietinOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | E2E529W34D | RECOMBINANT HUMAN THROMBOPOIETIN | One source FDA |
| NCI Thesaurus | C878 | Recombinant Human Thrombopoietin | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.